Protara Therapeutics (TARA) Accumulated Depreciation (2013 - 2025)

Protara Therapeutics (TARA) has 10 years of Accumulated Depreciation data on file, last reported at $1.5 million in Q4 2025.

• On a quarterly basis, Accumulated Depreciation rose 32.73% year-over-year to $1.5 million in Q4 2025; TTM through Dec 2025 was $1.5 million, a 32.73% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, up 32.73% from the prior year.
• Accumulated Depreciation for Q4 2025 stood at $1.5 million, up from $1.1 million in the prior quarter.
• Over the last five years, Accumulated Depreciation for TARA reached as high as $1.5 million in Q4 2025 and fell as low as $824000.0 in Q4 2023.
• Historically, Accumulated Depreciation has averaged $1.1 million across 3 years, with a median of $1.1 million in 2024.
• Across the five-year window, Accumulated Depreciation surged 34.22% in 2024 and soared 32.73% in 2025, its largest moves.
• Year by year, Accumulated Depreciation stood at $824000.0 in 2023, then jumped by 34.22% to $1.1 million in 2024, then surged by 32.73% to $1.5 million in 2025.
• Per Business Quant data, the three most recent Accumulated Depreciation figures were $1.5 million in Q4 2025, $1.1 million in Q4 2024, and $824000.0 in Q4 2023.